June 18th - 2009
Presentation at CRO-Biotech BIO-Connexion
18 June, 2009
Pelvipharm at the CRO-Biotech BIO-Connexion in Romainville, France
April 22nd - 2009
Recently accepted paper in Eur Urol
Combination of Alfuzosin and Tadalafil Exerts an Additive Relaxant Effect on Human Detrusor and Prostatic Tissues In Vitro
Oger S, Behr-Roussel D, Gorny D, Lebret T, Denoux Y, Alexandre L, Giuliano F.
Eur Urol. 2009 May 3. [Epub ahead of print]
April 25th - 2009
Presentations at the AUA 2009
Pelvipharm at the AUA (American Urological Association) in Chicago, USA, 25–30 april, 2009
Pelvipharm presented 3 abstracts:
- 1 Podium presentation :
“Ozarelix, an LHRH Antagonist, exerts a direct relaxing effect on Human Prostate in vitro”
April 23rd - 2009
Recently accepted paper in J Sex Med
Differences in the Spinal Command of Ejaculation in Rapid Ejaculating Rats.
Borgdorff AJ, Rössler AS, Clément P, Bernabé J, Alexandre L, Giuliano F.
J Sex Med 2009 Aug;6(8):2197-205
April 15th - 2009
Recently accepted paper in Urology
Ejaculatory Dysfunction and Its Association With Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia and BPH Treatment
Hellstrom WJ, Giuliano F, Rosen RC.
Urology. 2009 Jul;74(1):15-21
March 17th - 2009
Presentations at the EAU 2009
Pelvipharm at the EAU (European Association of Urology) in Stockholm, Sweden, 17–21 March 2009.
Pelvipharm presented 2 abstracts, oral sessions:
- “Patient reported outcomes by varying baseline intravaginal ejaculatory latency time in dapoxetine-treated men with premature ejaculation: Pooled analysis of 4 phase 3 trials”
- “Is relaxation of human detrusor by sildenafil relying on PDE 5 inhibition ?”
